1. Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma. Issue 1 (21st October 2019) Authors: Rajan, Arun; Heery, Christopher R.; Thomas, Anish; Mammen, Andrew L.; Perry, Susan; O'Sullivan Coyne, Geraldine; Guha, Udayan; Berman, Arlene; Szabo, Eva; Madan, Ravi A.; Ballester, Leomar Y.; Pittaluga, Stefania; Donahue, Renee N.; Tsai, Yo-Ting; Lepone, Lauren M.; Chin, Kevin; Ginty, Fiona; Soo... Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. In Situ Multiplex Immunofluorescence Analysis of Plasma Cell Myeloma Tissue Sections. (21st September 2018) Authors: Sood, Anup; Ginty, Fiona; Chadwick, Chrystal; Janz, Siegfried; Holman, Carol Journal: American journal of clinical pathology Issue: Volume 150(2018)Supplement 1 Page Start: S161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Novel DNA-based T-Cell Activator Promotes Rapid T-Cell Activation and Expansion. Issue 8 (October 2020) Authors: Keskar, Vandana; Sood, Anup; Loghin, Evelina; Kovacs, Ernest; Duthie, R. Scott; Liu, Shutong; Park, Jee Hyun; Chadwick, Chrystal; Smith, Reginald; Brown, Martin; Stroncek, David F.; Highfill, Steven L. Journal: Journal of immunotherapy Issue: Volume 43:Issue 8(2020:Oct.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗